AIM ImmunoTech Reports Positive Topline Results from Phase 2 Study Evaluating Ampligen® for the Treatment of Post-COVID Conditions

Efficacy results offer preliminary evidence that Ampligen may reduce fatigue in subjects with Post-COVID conditions Safety results show Ampligen is generally well tolerated in the treatment of...

Related Keywords

United States ,American ,Chris Mcaleer ,Thomask Equels ,Linkedin ,Exchange Commission ,Company Phase ,Twitter ,Facebook ,Immunotech Inc ,Fatigue Score ,Six Minute Walk Test ,Executive Officer Thomas ,Officer Chris Mcaleer ,Private Securities Litigation Reform Act ,Markets ,